Technology area: Chemistry & Materials
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Loparex Germany GmbH & Co. Kg is currently processing 3 pending office actions within the Chemistry & Materials technology area. These 3 actions are distributed across 3 distinct examiners, which means each pending matter is being handled by a different individual. This suggests that the company's pending chemistry applications are being reviewed by different specialists in different technical groups. The variety of examiners involved indicates that the company's materials science portfolio is being subjected to multiple independent perspectives during the examination process.
The busiest examiner for the company is FREEMAN, JOHN D, who handles 1 busiest examiner pending office action. While FREEMAN is the busiest examiner, the workload is split among the various examiners assigned to the portfolio. This distribution across multiple art units requires the company to manage separate prosecution tracks, each with its own examiner and technical focus within the materials sector. Practitioners should focus on the specific requirements of each examiner to ensure that the 3 pending office actions are resolved efficiently, as the lack of examiner overlap prevents a uniform strategy.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 3 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FREEMAN, JOHN D | 1 | 45.9% | +6.8% |
| SANDERS, JAMES M | 1 | 55.0% | +27.1% |
| GRUSBY, REBECCA LYNN | 1 | 32.3% | +41.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16961874 | PRINTED AND COATED RELEASE FOIL | GRUSBY, REBECCA LYNN | 9d overdue |
| 18844414 | DEEP-DRAWABLE SEPARATING FILM FOR FIBRE COMPOSITE PLASTIC COMPONENTS | FREEMAN, JOHN D | — |
| 18682595 | MULTI-LAYER FILM, COVER MATERIAL, ITS USE AND METHOD OF MANUFACTURE | SANDERS, JAMES M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16961874 | PRINTED AND COATED RELEASE FOIL | GRUSBY, REBECCA LYNN | 9d overdue |
| 18682595 | MULTI-LAYER FILM, COVER MATERIAL, ITS USE AND METHOD OF MANUFACTURE | SANDERS, JAMES M | — |
| Art Unit | Apps |
|---|---|
| 1744 | 1 |
| 1743 | 1 |
| 1785 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18844414 | DEEP-DRAWABLE SEPARATING FILM FOR FIBRE COMPOSITE PLASTIC COMPONENTS | FREEMAN, JOHN D | 1744 | §102§103§112 | Non-Final OA | — | Pending | Sep 06, 2024 |
| 18682595 | MULTI-LAYER FILM, COVER MATERIAL, ITS USE AND METHOD OF MANUFACTURE | SANDERS, JAMES M | 1743 | §103§112 | Non-Final OA | — | Pending | Feb 09, 2024 |
| 16961874 | PRINTED AND COATED RELEASE FOIL | GRUSBY, REBECCA LYNN | 1785 | §103§112 | Final Rejection | 9d overdue | Pending | Jul 13, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial